These $2,000 DNA tests aim to tell you which depression drug to take, but scientists are questioning whether they're worth it

Business Insider

There are now genetic tests that claim to tell you how you'll respond to depression drugs.

The tests can cost up to $2,000, and scientists are now questioning whether they're worth it.

Cancer genetics pioneer Myriad and a company called Genomind sell some of the most popular options, and patients can get them online or at some Albertsons pharmacies.

Silicon Valley DNA testing startup Color recently began offering one of the tests as well.

Read the full story on Business Insider.